Chart of the Week: Update: Unique Biomarkers in Pharma

On January 29th, we posted a CotW outlining the top 10 pharma companies by number of unique biomarkers those companies are using in trials.  We thought it was about time to update that chart and expand it to the top 25 pharma companies. Interesting facts to note:...

Precision Medicine Innovation Not Just a Numbers Game

We published a revision to our Precision Medicine Scorecard: Drug Company Edition last month. As John Audette rightfully notes, there are multiple factors in a pharmaceutical company’s contribution to precision medicines: How many precision medicines a company...

Chart of the Week: Celgene Precision Medicine Activities Graph

We’ve been curious about Celgene’s activity in precision medicine for some time.  We’ve posted blog posts here, here and here proposing that Celgene’s activities are indicative of a precision medicine push.  As a supplement, this weeks CotW is...

Report: Companion Diagnostic Biomarker Trends Report

Trends in biomarker types and uses, test development, and drug enablement are described in this new report, along with a breakdown of the companies that are doing the most to advance precision medicine. BEND, OR – May 3, 2016 – Amplion Inc., publisher of...